NDC Active Ingredient Certolizumab Pegol

Active Ingredient Information

What is Certolizumab Pegol?

A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.

What is the usage for Certolizumab Pegol?

This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis). Some brands may also be used to treat a certain type of spine condition (axial spondyloarthritis) or a certain bowel condition (Crohn's disease). Certolizumab belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by blocking TNF, a substance made by the body that causes inflammation.

How many products in the NDC database contain Certolizumab Pegol?

The NDC database has 1 products with the active ingredient Certolizumab Pegol. The following table lists all the products that have this active ingredient.

NDC Products with Certolizumab Pegol

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50474-710Proprietary Name: Cimzia Certolizumab PegolInjection, SolutionSubcutaneousUcb, Inc.ACTIVE